1620 INVESTMENT ADVISORS, INC.

Position in VTRS — Viatris Inc

CIK 1907281 PLYMOUTH, MA

Position in VTRS

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$384,153

-$37,318 QoQ

Shares Held

24,191

-22.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.37%

of 13F equity value

Holder Rank

#451

of 1,016 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 50% Shared 0% None 50%

Healthcare · as of Jun 30, 2026

1620 INVESTMENT ADVISORS, INC. holds $895,573 across 9 Drug Manufacturers - Specialty & Generic names. VTRS ranks #1 (42.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc This page	24,191	$384,153
2	UTHR	UNITED THERAPEUTICS Corp	356	$192,891
3	NBIX	Neurocrine Biosciences Inc	997	$168,034
4	TEVA	Teva Pharmaceutical Industries Ltd	1,577	$53,428
5	LNTH	Lantheus Holdings, Inc.	407	$45,152
6	PCRX	Pacira BioSciences, Inc.	834	$21,158
7	PAHC	Phibro Animal Health Corp	550	$17,270
8	AMPH	Amphastar Pharmaceuticals, Inc.	615	$12,410

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$384,153	24,191	-22.5%	Shares	Sole	2026-07-14
2026-03-31	$421,471	31,197	-32.5%	Shares	Sole	2026-05-13
2025-12-31	$575,252	46,205	0.0%	Shares	Sole	2026-02-05
2025-09-30	$457,429	46,205	+8617.9%	Shares	Sole	2025-10-07
2025-06-30	$4,732	530	-10.6%	Shares	Sole	2025-08-07
2025-03-31	$5,165	593	-97.3%	Shares	Sole	2025-05-14
2024-12-31	$275,331	22,115	+0.9%	Shares	Sole	2025-02-11
2024-09-30	$254,409	21,913	-0.4%	Shares	Sole	2024-10-25
2024-06-30	$233,881	22,002	0.0%	Shares	Sole	2024-07-23
2024-03-31	$262,703	22,002	+10.8%	Shares	Sole	2024-05-13
2023-12-31	$215,040	19,856	-55.6%	Shares	Sole	2024-02-09
2023-09-30	$440,949	44,721	-3.1%	Shares	Sole	2023-11-09
2023-06-30	$460,646	46,157	—	Shares	Sole	2023-08-14
No filing history on record for this holder in this stock.